IASIS Healthcare Announces Fourth Quarter and Year-End 2009 Results
IAS | Quote | Chart | News | PowerRating -- IASIS Healthcare(R) LLC ("IASIS") today announced financial and operating
results for the fiscal fourth quarter and year ended September 30, 2009.
Net revenue for the fourth quarter totaled $620.1 million, an increase
of 20.3%, compared to $515.4 million in the prior year quarter. Adjusted
EBITDA for the fourth quarter totaled $67.9 million, an increase of
17.2%, compared to $58.0 million, which includes $3.6 million in
hurricane-related property damage sustained as a result of Hurricane
Ike, in the prior year quarter. A table describing adjusted EBITDA and
reconciling net earnings from continuing operations to adjusted EBITDA
is included in this press release in the attached Supplemental
Consolidated Statements of Operations Information. Net loss from
continuing operations for the fourth quarter totaled $30.0 million,
compared to net earnings from continuing operations of $5.4 million in
the prior year quarter.
Included in the net loss from continuing operations for the fourth
quarter is a $64.6 million non-cash charge ($43.2 million after taxes)
for the impairment of goodwill related to the Florida market. The
Company has experienced changes in market conditions and the business
mix of its Florida operations, which negatively impacted operating
results in this market. Accordingly, the Company has written off the
goodwill associated with this market.
Admissions and adjusted admissions increased 4.2% and 4.7%,
respectively, in the fourth quarter, compared to the prior year quarter.
Excluding the impact of Hurricane Ike in the prior year quarter,
admissions and adjusted admissions increased 3.5% and 3.9%,
respectively, in the fourth quarter. Net patient revenue per adjusted
admission increased 8.2% in the fourth quarter, compared to the prior
year quarter.
Net revenue for the year ended September 30, 2009, totaled $2.4 billion,
an increase of 14.4%, compared to $2.1 billion in the prior year.
Adjusted EBITDA for the year ended September 30, 2009, totaled
$299.4 million, an increase of 13.0%, compared to $264.8 million, which
includes $3.6 million in hurricane-related property damage, in the prior
year. Net earnings from continuing operations for the year ended
September 30, 2009, which includes the impact of the Company's non-cash
charge related to the impairment of its goodwill, totaled $28.3 million,
compared to $47.6 million in the prior year.
For the year ended September 30, 2009, admissions decreased 0.2% and
adjusted admissions increased 2.4%, compared to the prior year. Net
patient revenue per adjusted admission increased 6.6% for the year ended
September 30, 2009, compared to the prior year.
Operating cash flows for the year ended September 30, 2009, were $272.0
million, compared to $143.4 million in the prior year. Strong operating
cash flows and effective capital management has resulted in significant
increases to free-cash-flow and the Company's overall cash position.
"We are pleased with our financial and operating results," said David R.
White, chairman and chief executive officer of IASIS Healthcare.
"Despite the difficulties of a prolonged economic recession, we continue
to achieve top-line and EBITDA growth, and our focus on liquidity and
effective capital management has helped to generate significant
improvements in our cash flow for the year. I believe these successes
highlight the excellence and commitment of our team. We are also
encouraged by the rebound in patient volumes that we have seen across
the back half of our 2009 fiscal year, and we hope to carry the momentum
of our success into the next fiscal year."
A listen-only simulcast and 30-day replay of IASIS' fourth quarter and
year-end conference call will be available by clicking the "For
Investors" link on the Company's Web site at www.iasishealthcare.com
beginning at 11:00 a.m. Eastern Time on November 24, 2009. A copy of
this press release will also be available on the Company's Web site.
IASIS, located in Franklin, Tennessee, is a leading owner and operator
of medium-sized acute care hospitals in high-growth urban and suburban
markets. The Company operates its hospitals with a strong community
focus by offering and developing healthcare services targeted to the
needs of the markets it serves, promoting strong relationships with
physicians and working with local managed care plans. IASIS owns or
leases 15 acute care hospital facilities and one behavioral health
hospital facility with a total of 2,853 beds in service and has total
annual net revenue of approximately $2.4 billion. These hospital
facilities are located in six regions: Salt Lake City, Utah; Phoenix,
Arizona; Tampa-St. Petersburg, Florida; three cities in Texas, including
San Antonio; Las Vegas, Nevada; and West Monroe, Louisiana. IASIS also
owns and operates a Medicaid and Medicare managed health plan in Phoenix
that serves over 190,000 members. For more information on IASIS, please
visit the Company's Web site at www.iasishealthcare.com.
Some of the statements we make in this press release are
forward-looking within the meaning of the federal securities laws, which
are intended to be covered by the safe harbors created thereby. Those
forward-looking statements include all statements that are not
historical statements of fact and those regarding our intent, belief or
expectations including, but not limited to, future financial and
operating results, the Company's plans, objectives, expectations and
other statements that are not historical facts. Forward-looking
statements involve known and unknown risks and uncertainties that may
cause actual results in future periods to differ materially from those
anticipated in the forward-looking statements. Those risks and
uncertainties include, among others, the risks and uncertainties related
to our ability to generate sufficient cash to service our existing
indebtedness, our substantial level of indebtedness that could adversely
affect our financial condition, the possibility of an increase in
interest rates, which would increase the cost of servicing our debt and
could reduce profitability, the fact we are controlled by our principal
equity sponsor, our ability to retain and negotiate reasonable contracts
with managed care plans, changes in legislation and regulations that may
significantly reduce government healthcare spending and our revenue and
may require us to make changes to our operations, our hospitals'
competition for patients from other hospitals and healthcare providers,
our hospitals facing a growth in volume and revenue related to
uncompensated care, our ability to recruit and retain quality
physicians, our hospitals' competition for staffing which may increase
our labor costs and reduce profitability, our failure to continually
enhance our hospitals with the most recent technological advances in
diagnostic and surgical equipment that may adversely affect our ability
to maintain and expand our markets, our failure to comply with extensive
laws and government regulations, the possible enactment of legislation
that would impose significant restrictions on hospitals that have
physician owners, the potential of exposure to liability from some of
our hospitals being required to submit to the Department of Health and
Human Services information on their relationships with physicians,
expenses incurred in connection with an appeal of the court order
dismissing with prejudice the qui tam litigation, the possibility that
we may become subject to federal and state investigations in the future,
our ability to satisfy regulatory requirements with respect to our
internal controls over financial reporting under Section 404 of the
Sarbanes-Oxley Act of 2002, a failure of our information systems that
would adversely affect our ability to properly manage our operations, an
economic downturn or other material change in any one of the regions in
which we operate, potential liabilities because of claims brought
against our facilities, increasing insurance costs that may reduce our
cash flows and net earnings, the impact of certain factors, including
severe weather conditions and natural disasters, on operations at our
hospitals, our ability to control costs at Health Choice Arizona, Inc.
("Health Choice"), the impact of any significant alteration to the
Arizona Health Care Cost Containment System's ("AHCCCS") payment
structure of its contracts or the amount of premiums paid to us, the
possibility of Health Choice's contract with the AHCCCS being
discontinued, significant competition from other healthcare companies
and state efforts to regulate the sale of not-for-profit hospitals that
may affect our ability to acquire hospitals, difficulties with the
integration of acquisitions that may disrupt our ongoing operations, the
significant capital expenditures that would be involved in the
construction of current or new projects that could have an adverse
effect on our liquidity, state efforts to regulate the construction or
expansion of hospitals that could impair our ability to operate and
expand our operations, our dependence on key personnel, the loss of one
or more of which could have a material adverse effect on our business,
potential responsibilities and costs under environmental laws that could
lead to material expenditures or liability, the possibility of a decline
in the fair value of our reporting units that could result in a material
non-cash charge to earnings and those risks, uncertainties and other
matters detailed in the Company's Annual Report on Form 10-K for the
fiscal year ended September 30, 2008, and other filings with the
Securities and Exchange Commission.
Although we believe that the assumptions underlying the
forward-looking statements contained in this press release are
reasonable, any of these assumptions could prove to be inaccurate, and,
therefore, there can be no assurance that the forward-looking statements
included in this press release will prove to be accurate. In
light of the significant uncertainties inherent in the forward-looking
statements included herein, you should not regard the inclusion of such
information as a representation by the Company or any other person that
our objectives and plans will be achieved. We undertake no
obligation to publicly release any revisions to any forward-looking
statements contained herein to reflect events and circumstances
occurring after the date hereof or to reflect the occurrence of
unanticipated events.
IASIS HEALTHCARE LLC
Consolidated Statements of Operations (Unaudited)
(in thousands)
Quarter Ended Year Ended
September 30, September 30,
2009 2008 2009 2008
Net revenue:
Acute care revenue $ 424,963 $ 374,495 $ 1,662,469 $ 1,523,790
Premium revenue 195,093 140,924 699,503 541,746
Total net revenue 620,056 515,419 2,361,972 2,065,536
Costs and expenses:
Salaries and benefits 165,534 156,786 660,921 632,109
Supplies 63,044 54,135 250,573 231,259
Medical claims 170,241 118,403 592,760 452,055
Other operating expenses 88,724 74,006 325,735 283,123
Provision for bad debts 54,671 41,097 192,563 161,936
Rentals and leases 9,906 9,435 39,127 36,633
Interest expense, net 16,761 17,205 67,890 75,665
Depreciation and amortization 23,953 25,598 97,462 96,741
Management fees 1,250 1,250 5,000 5,000
Impairment of goodwill 64,639 - 64,639 -
Hurricane-related property damage - 3,589 938 3,589
Total costs and expenses 658,723 501,504 2,297,608 1,978,110
Earnings (loss) from continuing operations (38,667 ) 13,915 64,364 87,426
before gain (loss) on disposal of assets,
minority interests and income taxes
Gain (loss) on disposal of assets, net (32 ) (95 ) 1,465 (75 )
Minority interests (2,747 ) (1,329 ) (9,987 ) (4,437 )
Earnings (loss) from continuing operations (41,446 ) 12,491 55,842 82,914
before income taxes
Income tax expense (benefit) (11,399 ) 7,045 27,576 35,325
Net earnings (loss) from continuing operations (30,047 ) 5,446 28,266 47,589
Earnings (loss) from discontinued operations, net of income taxes 157 (4,927 ) (176 ) (11,275 )
Net earnings (loss) $ (29,890 ) $ 519 $ 28,090 $ 36,314
IASIS HEALTHCARE LLC
Consolidated Balance Sheets
(in thousands)
Sept. 30, Sept. 30,
2009 2008
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 206,528 $ 80,738
Accounts receivable, net 230,198 224,138
Inventories 50,492 49,454
Deferred income taxes 39,038 38,860
Prepaid expenses and other current assets 49,453 60,053
Total current assets 575,709 453,243
Property and equipment, net 997,353 1,004,248
Goodwill 717,920 780,599
Other intangible assets, net 30,000 33,000
Other assets, net 36,222 37,057
Total assets $ 2,357,204 $ 2,308,147
LIABILITIES AND MEMBER'S EQUITY
Current liabilities:
Accounts payable $ 68,552 $ 64,851
Salaries and benefits payable 42,548 31,807
Accrued interest payable 12,511 12,460
Medical claims payable 113,519 97,343
Other accrued expenses and other current liabilities 65,701 51,802
Current portion of long-term debt and capital lease obligations 8,366 7,623
Total current liabilities 311,197 265,886
Long-term debt and capital lease obligations 1,051,471 1,106,999
Deferred income taxes 106,425 111,092
Other long-term liabilities 54,222 44,526
Minority interests 53,042 51,875
Member's equity 780,847 727,769
Total liabilities and member's equity $ 2,357,204 $ 2,308,147
IASIS HEALTHCARE LLC
Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
Year Ended
September 30,
2009 2008
Cash flows from operating activities:
Net earnings $ 28,090 $ 36,314
Adjustments to reconcile net earnings to net cash provided by
operating activities:
Loss from discontinued operations 176 11,275
Depreciation and amortization 97,462 96,741
Amortization of loan costs 3,029 2,913
Minority interests 9,987 4,437
Income tax benefit from parent company interest 27,344 -
Deferred income taxes (5,572 ) 19,368
Loss (gain) on disposal of assets, net (1,465 ) 75
Impairment of goodwill 64,639 -
Hurricane-related property damage 938 3,589
Stock compensation costs 561 -
Changes in operating assets and liabilities, net of the effect of
acquisitions and dispositions:
Accounts receivable, net (7,302 ) 17,131
Inventories, prepaid expenses and other current assets 6,728 (21,361 )
Accounts payable, other accrued expenses and other accrued 45,884 (29,419 )
liabilities
Net cash provided by operating activities - continuing operations 270,499 141,063
Net cash provided by operating activities - discontinued operations 1,472 2,313
Net cash provided by operating activities 271,971 143,376
Cash flows from investing activities:
Purchases of property and equipment, net (87,720 ) (137,415 )
Cash paid for acquisitions, net (1,941 ) (16,821 )
Proceeds from sale of assets 5,252 360
Change in other assets, net 1,823 4,613
Net cash used in investing activities - continuing operations (82,586 ) (149,263 )
Net cash provided by (used in) investing activities - discontinued 10 (1,017 )
operations
Net cash used in investing activities (82,576 ) (150,280 )
Cash flows from financing activities:
Proceeds from debt borrowings - 384,978
Payment of debt and capital lease obligations (55,476 ) (306,611 )
Distribution of minority interests (6,750 ) (5,485 )
Proceeds received from sale (costs paid for repurchase) of (1,379 ) 15,070
partnership
interests, net
Other - 192
Net cash provided by (used in) financing activities - continuing (63,605 ) 88,144
operations
Net cash used in financing activities - discontinued operations - (502 )
Net cash provided by (used in) financing activities (63,605 ) 87,642
Change in cash and cash equivalents 125,790 80,738
Cash and cash equivalents at beginning of period 80,738 -
Cash and cash equivalents at end of period $ 206,528 $ 80,738
Supplemental disclosure of cash flow information:
Cash paid for interest $ 66,136 $ 83,126
Cash paid (received) for income taxes, net $ 4,104 $ (925 )
IASIS HEALTHCARE LLC
Segment Information (Unaudited)
(in thousands)
For the Quarter Ended September 30, 2009
Acute Care Health Choice Eliminations Consolidated
Acute care revenue $424,963 $ - $ - $424,963
Premium revenue - 195,093 - 195,093
Revenue between segments 2,765 - (2,765 ) -
Net revenue 427,728 195,093 (2,765 ) 620,056
Salaries and benefits 161,259 4,275 - 165,534
Supplies 62,994 50 - 63,044
Medical claims - 173,006 (2,765 ) 170,241
Other operating expenses 82,532 6,192 - 88,724
Provision for bad debts 54,671 - - 54,671
Rentals and leases 9,525 381 - 9,906
Adjusted EBITDA (1) 56,747 11,189 - 67,936
Interest expense, net 16,761 - - 16,761
Depreciation and amortization 23,154 799 - 23,953
Impairment of goodwill 64,639 - - 64,639
Management fees 1,250 - - 1,250
Earnings (loss) from continuing operations before gain (loss) on (49,057 ) 10,390 - (38,667 )
disposal of assets, minority interests and income taxes
Gain (loss) on disposal of assets, net 119 (151 ) - (32 )
Minority interests (2,747 ) - - (2,747 )
Earnings (loss) from continuing operations before income taxes $(51,685 ) $ 10,239 $ - $(41,446 )
For the Quarter Ended September 30, 2008
Acute Care Health Choice Eliminations Consolidated
Acute care revenue $ 374,495 $- $ - $ 374,495
Premium revenue - 140,924 - 140,924
Revenue between segments 2,324 - (2,324 ) -
Net revenue 376,819 140,924 (2,324 ) 515,419
Salaries and benefits 151,963 4,823 - 156,786
Supplies 54,058 77 - 54,135
Medical claims - 120,727 (2,324 ) 118,403
Other operating expenses 69,142 4,864 - 74,006
Provision for bad debts 41,097 - - 41,097
Rentals and leases 9,155 280 - 9,435
Hurricane-related property damage 3,589 - - 3,589
Adjusted EBITDA (1) 47,815 10,153 - 57,968
Interest expense, net 17,205 - - 17,205
Depreciation and amortization 24,578 1,020 - 25,598
Management fees 1,250 - - 1,250
Earnings from continuing operations before loss on disposal of 4,782 9,133 - 13,915
assets, minority interests and income taxes
Loss on disposal of assets, net (95 ) - - (95 )
Minority interests (1,329 ) - - (1,329 )
Earnings from continuing operations before income taxes $ 3,358 $9,133 $ - $ 12,491
(1) Adjusted EBITDA represents net earnings (loss) from
continuing operations before interest expense, income tax expense
(benefit), depreciation and amortization, impairment of goodwill,
gain (loss) on disposal of assets, minority interests and
management fees. Management fees represent monitoring and advisory
fees paid to TPG, the Company's majority financial sponsor, and
certain other members of IASIS Investment LLC. Management
routinely calculates and communicates adjusted EBITDA and believes
that it is useful to investors because it is commonly used as an
analytical indicator within the healthcare industry to evaluate
hospital performance, allocate resources and measure leverage
capacity and debt service ability. In addition, the Company uses
adjusted EBITDA as a measure of performance for its business
segments and for incentive compensation purposes. Adjusted EBITDA
should not be considered as a measure of financial performance
under generally accepted accounting principles ("GAAP"), and the
items excluded from adjusted EBITDA are significant components in
understanding and assessing financial performance. Adjusted EBITDA
should not be considered in isolation or as an alternative to net
earnings, cash flows generated by operating, investing, or
financing activities or other financial statement data presented
in the consolidated financial statements as an indicator of
financial performance or liquidity. Adjusted EBITDA, as presented,
differs from what is defined under the Company's senior secured
credit facilities and may not be comparable to similarly titled
measures of other companies.
IASIS HEALTHCARE LLC
Segment Information (Unaudited)
(in thousands)
For the Year Ended September 30, 2009
Acute Care Health Choice Eliminations Consolidated
Acute care revenue $1,662,469 $- $- $1,662,469
Premium revenue - 699,503 - 699,503
Revenue between segments 9,316 - (9,316 ) -
Net revenue 1,671,785 699,503 (9,316 ) 2,361,972
Salaries and benefits 641,893 19,028 - 660,921
Supplies 250,310 263 - 250,573
Medical claims - 602,076 (9,316 ) 592,760
Other operating expenses 302,804 22,931 - 325,735
Provision for bad debts 192,563 - - 192,563
Rentals and leases 37,563 1,564 - 39,127
Hurricane-related property damage 938 - - 938
Adjusted EBITDA (1) 245,714 53,641 - 299,355
Interest expense, net 67,890 - - 67,890
Depreciation and amortization 94,014 3,448 - 97,462
Impairment of goodwill 64,639 - - 64,639
Management fees 5,000 - - 5,000
Earnings before gain (loss) on disposal of assets, minority 14,171 50,193 - 64,364
interests and income taxes
Gain (loss) on disposal of assets, net 1,616 (151 ) - 1,465
Minority interests (9,987 ) - - (9,987 )
Earnings from continuing operations before income taxes $5,800 $50,042 $- $55,842
Segment assets $2,109,422 $247,782 $2,357,204
Capital expenditures - continuing operations $86,875 $845 $87,720
Goodwill $712,163 $5,757 $717,920
For the Year Ended September 30, 2008
Acute Care Health Choice Eliminations Consolidated
Acute care revenue $1,523,790 $- $- $1,523,790
Premium revenue - 541,746 - 541,746
Revenue between segments 9,594 - (9,594 ) -
Net revenue 1,533,384 541,746 (9,594 ) 2,065,536
Salaries and benefits 614,442 17,667 - 632,109
Supplies 231,001 258 - 231,259
Medical claims - 461,649 (9,594 ) 452,055
Other operating expenses 264,814 18,309 - 283,123
Provision for bad debts 161,936 - - 161,936
Rentals and leases 35,466 1,167 - 36,633
Hurricane-related property damage 3,589 - - 3,589
Adjusted EBITDA (1) 222,136 42,696 - 264,832
Interest expense, net 75,665 - - 75,665
Depreciation and amortization 93,003 3,738 - 96,741
Management fees 5,000 - - 5,000
Earnings from continuing operations before loss on disposal of 48,468 38,958 - 87,426
assets, minority interests and income taxes
Loss on disposal of assets, net (75 ) - - (75 )
Minority interests (4,437 ) - - (4,437 )
Earnings from continuing operations before income taxes $43,956 $38,958 $- $82,914
Segment assets $2,123,069 $185,078 $2,308,147
Capital expenditures - continuing operations $136,425 $990 $137,415
Goodwill $774,842 $5,757 $780,599
(1) Adjusted EBITDA represents net earnings from
continuing operations before interest expense, income tax expense,
depreciation and amortization, impairment of goodwill, gain (loss)
on disposal of assets, minority interests and management fees.
Management fees represent monitoring and advisory fees paid to
TPG, the Company's majority financial sponsor, and certain other
members of IASIS Investment LLC. Management routinely calculates
and communicates adjusted EBITDA and believes that it is useful to
investors because it is commonly used as an analytical indicator
within the healthcare industry to evaluate hospital performance,
allocate resources and measure leverage capacity and debt service
ability. In addition, the Company uses adjusted EBITDA as a
measure of performance for its business segments and for incentive
compensation purposes. Adjusted EBITDA should not be considered as
a measure of financial performance under GAAP, and the items
excluded from adjusted EBITDA are significant components in
understanding and assessing financial performance. Adjusted EBITDA
should not be considered in isolation or as an alternative to net
earnings, cash flows generated by operating, investing, or
financing activities or other financial statement data presented
in the consolidated financial statements as an indicator of
financial performance or liquidity. Adjusted EBITDA, as presented,
differs from what is defined under the Company's senior secured
credit facilities and may not be comparable to similarly titled
measures of other companies.
IASIS HEALTHCARE LLC
Consolidated Financial and Operating Data (Unaudited)
Quarter Ended Year Ended
September 30, September 30,
2009 2008 2009 2008
Consolidated Hospital Facilities
Number of acute care hospital facilities at 15 15 15 15
end of period
Beds in service at end of period 2,853 2,644 2,853 2,644
Average length of stay (days) 4.7 4.5 4.7 4.7
Occupancy rates (average beds in service) 45.4% 45.4% 47.0% 48.9%
Admissions 25,455 24,419 101,083 101,302
Percentage change 4.2% (0.2)%
Adjusted admissions 43,106 41,152 169,721 165,819
Percentage change 4.7% 2.4%
Patient days 119,269 110,481 473,601 471,853
Adjusted patient days 192,935 178,507 762,234 741,466
Outpatient revenue as a % of gross patient revenue 39.7% 39.3% 39.0% 36.9%
IASIS HEALTHCARE LLC
Supplemental Consolidated Statements of Operations Information
(Unaudited)
(in thousands)
Quarter Ended Year Ended
September 30, September 30,
2009 2008 2009 2008
Consolidated Results
Net earnings (loss) from continuing operations $ (30,047 ) $ 5,446 $ 28,266 $ 47,589
Add:
Interest expense, net 16,761 17,205 67,890 75,665
Income tax expense (benefit) (11,399 ) 7,045 27,576 35,325
Depreciation and amortization 23,953 25,598 97,462 96,741
Impairment of goodwill 64,639 - 64,639 -
Loss (gain) on disposal of assets, net 32 95 (1,465 ) 75
Minority interests 2,747 1,329 9,987 4,437
Management fees 1,250 1,250 5,000 5,000
Adjusted EBITDA (1) $ 67,936 $ 57,968 $ 299,355 $ 264,832
(1) Adjusted EBITDA represents net earnings (loss) from
continuing operations before interest expense, income tax expense
(benefit), depreciation and amortization, impairment of goodwill,
loss (gain) on disposal of assets, minority interests and
management fees. Management fees represent monitoring and advisory
fees paid to TPG, the Company's majority financial sponsor, and
certain other members of IASIS Investment LLC. Management
routinely calculates and communicates adjusted EBITDA and believes
that it is useful to investors because it is commonly used as an
analytical indicator within the healthcare industry to evaluate
hospital performance, allocate resources and measure leverage
capacity and debt service ability. In addition, the Company uses
adjusted EBITDA as a measure of performance for its business
segments and for incentive compensation purposes. Adjusted EBITDA
should not be considered as a measure of financial performance
under GAAP, and the items excluded from adjusted EBITDA are
significant components in understanding and assessing financial
performance. Adjusted EBITDA should not be considered in isolation
or as an alternative to net earnings, cash flows generated by
operating, investing, or financing activities or other financial
statement data presented in the consolidated financial statements
as an indicator of financial performance or liquidity. Adjusted
EBITDA, as presented, differs from what is defined under the
Company's senior secured credit facilities and may not be
comparable to similarly titled measures of other companies.
SOURCE: IASIS Healthcare LLC
IASIS Healthcare LLC
Investor contact:
W. Carl Whitmer, 615-844-2747
Chief Financial Officer
or
Media contact:
Michele M. Peden, 615-467-1255
VP, Corporate Communications
For full details on (IAS) IAS. (IAS) has Short Term PowerRatings at TradingMarkets. Details on (IAS) Short Term PowerRatings is available at This Link.
- IASIS Healthcare to Broadcast Its Fiscal First Quarter 2010 Conference Call Live on the Internet - 02/04/10
- Iasis Healthcare Repurchases $120 Million of Its Preferred Stock - 01/21/10
- Iasis Healthcare Repurchases $120 Million of Its Preferred Stock - 01/20/10
- IASIS Healthcare Repurchases $120 Million in Preferred Stock - 01/19/10
- IASIS Healthcare is the First System to Achieve DNV Accreditation at All of Its Hospitals - 12/17/09
- More News >>


